Tarsus Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 162.1M | 151.7M | 118.7M | 102.7M | 78.3M | 66.4M | 48.1M | 40.8M |
| Cost of Goods Sold | 9.4M | 10.9M | 24.6M | 6.2M | 5.2M | 4.9M | 3.2M | 3.0M |
| Gross Profit | 152.7M | 140.7M | 94.1M | 96.4M | 73.1M | 61.5M | 44.9M | 37.8M |
| R&D Expenses | 22.4M | 18.0M | 16.3M | 15.6M | 14.4M | 16.9M | 12.1M | 12.3M |
| Operating Expenses | 158.8M | 148.7M | 108.6M | 118.6M | 99.4M | 85.9M | 70.0M | 71.1M |
| Operating Income | -6.1M | -8.0M | -14.5M | -22.2M | -26.3M | -24.4M | -25.2M | -33.3M |
| Other Income / Gains | -3.2M | 1.7M | 1.9M | 1.8M | 1.2M | 1.3M | 1.7M | 12K |
| Net Income | -7.0M | -8.4M | -12.6M | -20.3M | -25.1M | -23.1M | -23.4M | -33.3M |
| EPS (Diluted) | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.942 | 0.928 | 0.793 | 0.939 | 0.933 | 0.926 | 0.933 | 0.926 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 136.4M | 130.7M | 108.6M | 103.0M | 85.0M | 69.0M | 57.9M | 58.8M |
| Other Expenses | 0 | 0 | -16.3M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 168.2M | 159.6M | 133.2M | 124.8M | 104.6M | 90.8M | 73.3M | 74.1M |
| Interest Income | 3.7M | 4.0M | 1.8M | 4.2M | 3.5M | 3.6M | 4.1M | 4.1M |
| Interest Expense | 2.1M | 2.2M | 0 | 2.1M | 2.1M | 2.2M | 2.3M | 2.1M |
| Depreciation And Amortization | 437K | 443K | 460K | 453K | 460K | 432K | 300K | 239K |
| Ebitda | -5.7M | -3.7M | -12.1M | -17.6M | -22.4M | -20.4M | -20.7M | -30.9M |
| Ebitdaratio | -0.035 | -0.024 | -0.102 | -0.172 | -0.287 | -0.307 | -0.43 | -0.758 |
| Operating Income Ratio | -0.038 | -0.053 | -0.122 | -0.216 | -0.335 | -0.368 | -0.523 | -0.816 |
| Income Before Tax | -9.3M | -6.3M | -12.6M | -20.3M | -25.1M | -23.1M | -23.4M | -33.3M |
| Income Before Tax Ratio | -0.058 | -0.042 | -0.106 | -0.198 | -0.321 | -0.348 | -0.487 | -0.816 |
| Income Tax Expense | -2.4M | 2.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.043 | -0.055 | -0.106 | -0.198 | -0.321 | -0.348 | -0.487 | -0.816 |
| Epsdiluted | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 |
| Weighted Average Shs Out | 43.0M | 42.8M | 42.6M | 42.4M | 39.3M | 38.6M | 38.4M | 37.8M |
| Weighted Average Shs Out Dil | 43.0M | 42.8M | 42.6M | 42.4M | 39.3M | 38.6M | 38.4M | 37.8M |